Hydroxocobalamin Orion (Hydroxocobalamin)

Hydroxocobalamin serves as a cofactor for methionine synthase and methylmalonyl‑CoA mutase, enzymes essential for DNA synthesis, myelin formation, and red blood cell production. By donating a methyl group, it converts homocysteine to methionine and supports the metabolism of odd‑chain fatty acids, thereby correcting the metabolic disturbances caused by cobalamin deficiency.

The specific dose and frequency are determined by the prescribing clinician based on the severity of deficiency, patient weight, and clinical response. Dosing regimens can range from a single loading dose to multiple weekly or monthly injections, and the prescriber will tailor the schedule to each individual’s needs.

Data on the use of injectable hydroxocobalamin in pregnancy and lactation are limited. Because vitamin B12 is essential for fetal development, the drug may be used when the potential benefit outweighs any theoretical risk. Pregnant or nursing patients should discuss treatment with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team then provides pricing, availability, shipping details—including any cold‑chain requirements—and assists with import documentation.

Hydroxocobalamin has a longer plasma half‑life and higher affinity for tissue binding compared with cyanocobalamin, making it useful for sustained cobalamin repletion. It also has the ability to bind cyanide, providing an additional antidotal benefit. Choice of preparation depends on clinical context, availability, and physician preference.

The product should be stored at 2‑8 °C in a refrigerator, protected from light and moisture. Do not freeze or shake the vial. Before administration, allow the solution to reach room temperature if required, and inspect for particulate matter or discoloration. Follow standard aseptic techniques during preparation and injection.

Hydroxocobalamin Orion is given by intramuscular injection, typically into the deltoid or gluteal muscle. The injection should be performed using aseptic technique, with the appropriate needle length to ensure deep muscle delivery. The prescriber determines the injection volume and schedule based on the patient’s clinical condition.

Serious adverse events, although rare, include anaphylactic reactions, severe hypotension, and life‑threatening skin reactions such as Stevens‑Johnson syndrome. Immediate medical attention is required if signs of an allergic reaction, sudden drop in blood pressure, or extensive skin involvement occur after injection.

Hydroxocobalamin Orion is contraindicated in individuals with a known hypersensitivity to hydroxocobalamin or any component of the formulation. Caution is advised in patients with severe renal impairment, and intravascular administration should be avoided. Patients with a history of severe allergic reactions to vitamin B12 preparations should discuss alternatives with their clinician.